Back
Abbott Laboratories Quote, Financials, Valuation and Earnings
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.
Buy
60
ABT
Abbott Laboratories
Last Price:
105.26
Seasonality Move:
2.22%
7 Day Trial
ALL ACCESS PASS
$
7
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.Abbott Laboratories Price Quote
$105.26
-0.70 (-0.66%)
(Updated: July 26, 2024 at 6:55 PM ET)
Abbott Laboratories Key Stats
Buy
60
Abbott Laboratories (ABT)
is a Buy
Day range:
$105.92 - $108.71
52-week range:
$89.67 - $121.64
Dividend yield:
2.04%
P/E ratio:
32.50
P/S ratio:
4.55
P/B ratio:
4.75%
Volume:
6.3M
Avg. volume:
6.4M
1-year change:
-6.17%
Market cap:
$184.3B
Revenue:
$40.1B
EPS:
$3.17
How Much Does Abbott Laboratories Make?
-
How Much Are Abbott Laboratories's Sales Annually?
ABT Revenues are $40.1B -
How Much Profit Does Abbott Laboratories's Make A Year?
ABT net income is $5.7B
Is Abbott Laboratories Growing As A Company?
-
What Is Abbott Laboratories's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.04% -
What Is Abbott Laboratories's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.05%
Abbott Laboratories Stock Price Performance
-
Did Abbott Laboratories Stock Go Up Last Month?
Abbott Laboratories share price went up by 0.45% last month -
Did ABT's Share Price Rise Over The Last Year?
ABT share price fell by -6.17% over the past 1 year
What Is Abbott Laboratories 52-Week High & Low?
-
What Is Abbott Laboratories’s 52-Week High Share Price?
Abbott Laboratories has traded as high as $121.64 over the past 52 weeks -
What Is Abbott Laboratories’s 52-Week Low Share Price?
Abbott Laboratories has traded as low as $89.67 over the past 52 weeks
Abbott Laboratories Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Abbott Laboratories?
-
How Much Debt Does Abbott Laboratories Have?
Total long term debt quarterly is $0 -
How Much Cash Does Abbott Laboratories Have?
Cash and short term investments quarterly total is $6.7B -
What Is Abbott Laboratories’s Book Value Per Share?
Book value per share is 22.31
Is Abbott Laboratories Cash Flow Positive?
-
What Is ABT Cash Flow From Operations?
Cash flow from operations (TTM) is $7.1B -
What Is Abbott Laboratories’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$6.9B -
What Is Abbott Laboratories’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$3.1B
Abbott Laboratories Return On Invested Capital
-
Is Management Doing A Good Job?
ABT return on invested capital is 10.36% -
What Is Abbott Laboratories Return On Assets?
ROA measures how assets are converting to revenues and is 7.64% -
What Is ABT Return On Equity?
ROE is a measure of profitability and is 14.8%
Abbott Laboratories Earnings Date & Stock Price
-
What Is Abbott Laboratories's Stock Price Today?
A single share of ABT can be purchased today for 105.96 -
What Is Abbott Laboratories’s Stock Symbol?
Abbott Laboratories trades on the S&P500 under the ticker symbol: ABT -
When Is Abbott Laboratories’s Next Earnings Date?
The next quarterly earnings date for Abbott Laboratories is scheduled on October 18, 2024 -
When Is ABT's next ex-dividend date?
Abbott Laboratories's next ex-dividend date is July 15, 2024 -
How To Buy Abbott Laboratories Stock?
You can buy Abbott Laboratories shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Abbott Laboratories Competitors
-
Who Are Abbott Laboratories's Competitors?
Below is a list of companies who compete with Abbott Laboratories or are related in some way:
Abbott Laboratories Dividend Yield
-
What Is ABT Dividend Yield?
Abbott Laboratories’s dividend yield currently is 2.04% -
What Is Abbott Laboratories’s Payout Ratio?
Abbott Laboratories’s payout ratio is 49.18% -
When Did Abbott Laboratories Last Pay A Dividend?
The latest dividend pay date is July 26, 2024 -
What Is Abbott Laboratories’s Dividend Per Share?
Abbott Laboratories pays a dividend of $0.55 per share
Abbott Laboratories Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -5.13% | 3.17% |
| Revenue: | 4% | 0.08% |
Analyst Recommendations
| Buy Recommendations: | 12 |
|---|---|
| Hold Recommendations: | 6 |
| Sell Recommendations: | 0 |
| Price Target: | 124.47 |
| Upside from Last Price: | 17.47% |